Content about Adipose tissue

February 25, 2014

The Food and Drug Administration has approved Myalept (metreleptin for injection) to treat complications of leptin deficiency in patients with congenital generalized or acquired generalized lipodystrophy, a condition associated with a lack of fat tissue.

SILVER SPRING, Md. — The Food and Drug Administration has approved Myalept (metreleptin for injection) to treat complications of leptin deficiency in patients with congenital generalized or acquired generalized lipodystrophy, which is a condition associated with a lack of fat tissue.

January 14, 2013

A new study indicates that body mass index is a reliable indicator of obesity-related health risks.

NEW YORK — A new study indicates body mass index is a reliable indicator of obesity-related health risks.

The study, published Saturday in the journal Obesity Research and Clinical Practice, compared the merits of BMI to other measures of body size as a predictor of obesity-related cardiovascular health risks. The study's authors noted that some have questioned the validity of BMI.

July 6, 2011

People with lower percentages of body fat are not necessarily at lower risk for diabetes and heart disease, according to a new international study.

BOSTON — People with lower percentages of body fat are not necessarily at lower risk for diabetes and heart disease, according to a new international study.

The study identified a gene that is linked with having less body fat but also with having an increased risk of Type 2 diabetes and heart disease. The investigators examined the genomes of more than 75,000 people and found that the gene, IRS1, was linked to less body fat, but also to unhealthy levels of cholesterol and blood glucose.